ENTITY
Jcr Pharmaceuticals

Jcr Pharmaceuticals (4552 JP)

58
Analysis
Health Care • Japan
JCR Pharmaceuticals Co., Ltd. develops, produces, and sells pharmaceutical products and raw materials. The Company also sells equipment for hospital and laboratory use. JCR Pharmaceuticals' products include drug for leukemic diseases and hormonal agents including genetically engineered human somatotrophic hormone (growth hormone) and gonadotropic hormone.
more
•09 Sep 2019 08:22

Global Equity Strategy: Guarded Optimism

Global equities (MSCI ACWI) are decisively breaking above 1-month resistance on US-China trade war optimism, incrementally improving the technical...

Logo
528 Views
Share
•24 Aug 2019 06:23

Global Equity Strategy: Bearish-Leaning Developments Continue; Europe/UK Holding Above Support.

We remain cautious as the number of bearish-leaning developments continue to pile up. As a result we continue to believe global equities are...

Logo
521 Views
Share
bullish•Nippon Shinyaku
•28 May 2026 08:30

Nippon Shinyaku (4516 JP): FY27 Guidance Signals Recovery, Speed Bumps Remain

​Nippon Shinyaku's FY26 revenue grew 7% to ¥170B, driven by ethical drugs and higher licensing fees. FY27 revenue expected to reach ¥200B with...

Logo
121 Views
Share
•25 May 2026 08:00

Kissei Pharma (4547 JP): FY27 Guidance Revealed, Tavneos Hiccup Amid Linzagolix Positives

​Kissei Pharmaceutical revenue grows driven by Beova, Tavneos, and IT services despite challenges. Expects drop in revenue for FY27. Linzagolix...

Logo
130 Views
Share
•19 Sep 2018 15:25

Japan: Most Overbought and Oversold - Relative Price Score Update - Companies

RELATIVE PRICE SCORE - The Relative Price Score (RPS) measures stock price performance relative to TOPIX and is calculated by comparing the current...

Logo
608 Views
Share
x